About Microstructure Imaging

Microstructure Imaging (MICSI) is a healthcare AI company that develops software solutions to enhance the image quality and diagnostic capabilities of existing MRI and PET scanners. Their technology aims to provide faster scans, higher image resolution, and unlock new diagnostic capabilities by improving the signal-to-noise ratio (SNR) in medical images. MICSI’s approach differs from traditional AI methods as it achieves these results without the need for external training data or high-performance GPUs.

This leads to improved visualization of small structures in brain white matter and better contrast to distinguish adjacent tissue types. Their second product, MICSI-PET, applies a similar physics-based enhancement to PET imaging, enabling anatomically precise, higher-resolution amyloid and tau PET on existing scanners, along with automated quantification for amyloid and tau. This can be particularly beneficial in borderline amyloid cases, making patterns substantially easier to see and providing a more powerful way to evaluate examinations with automated quantification. The software integrates into existing clinical imaging workflows, enhancing current PET infrastructure.

Focus Areas

MRI image quality enhancement denoising neuroimaging prostate imaging quantitative analysis of diffusion-weighted imaging reducing MRI scan time increasing MRI resolution Alzheimer's care

Business Intelligence

TechnologyCloud-native (implied), Random Matrix Theory-based algorithm (MP-PCA denoising method), DICOM data routing, self-supervised AI (does not require external training data or high-performance GPUs)

What Physicians Need to Know

MRI Image Quality Enhancement & Denoising
Microstructure Imaging (MICSI) specializes in enhancing MRI and PET image quality through advanced denoising techniques. Their FDA 510(k) cleared MICSI-RMT software significantly improves the signal-to-noise ratio (SNR) for diffusion MRI (dMRI) by up to 4.35x and functional MRI (fMRI) by 1.9x, leading to clearer images and reduced artifacts. They also have MICSI-PET, which is FDA 510(k) submitted, for PET image enhancement with automated amyloid and tau quantification. This technology is particularly beneficial for diffusion-weighted imaging (DWI), which often suffers from high noise levels.
Neuroimaging
The company's technologies are vital for analyzing and visualizing neural anatomy in both normal and diseased states, especially for understanding white matter anatomy and pathology in the brain. Their work includes developing microstructural imaging biomarkers and personalized anatomical analysis methods. MICSI-RMT has shown improved visualization of small structures in brain white matter and enhanced contrast to distinguish adjacent tissue types. They also offer automated quantification for amyloid and tau PET, along with regional SUVr measurements and z-scores for neurological PET. Diffusion MRI is a key technique used to study brain microstructure and neurological integrity, and MICSI's advancements can help detect subtle changes in cellular integrity and organization related to neurological disorders.
Prostate Imaging
Microstructure Imaging addresses the challenges of prostate imaging, particularly in diffusion-weighted imaging (DWI) for prostate cancer detection and characterization. Their methods aim to improve the efficiency of clinical prostate diffusion acquisitions, allowing for the measurement of fractional anisotropy (FA) in addition to the apparent diffusion coefficient (ADC) by varying diffusion directions instead of relying solely on repeated averages. This can lead to superior diagnostic performance for prostate cancer.
Quantitative Analysis of Diffusion-Weighted Imaging (DWI)
MICSI develops and implements quantitative measures from diffusion MRI (dMRI), including multi-shell dMRI, compressed sensing in conjunction with MRS, and double-pulsed field gradient dMRI. Their MICSI-RMT software includes processing modules that support weighted linear least squares and Bayesian fitting techniques for quantitative analysis of diffusion-weighted imaging. This allows for more precise characterization of microstructural changes in tissues.
Reducing MRI Scan Time & Increasing MRI Resolution
A core goal of Microstructure Imaging is to decrease MRI scan time and increase image resolution. Their denoising algorithm can process low SNR signals without the limitations of inadequate noise removal or signal distortion, potentially allowing for high-quality images at drastically shorter scan times. This can improve patient comfort, increase imaging throughput, and make advanced imaging techniques more accessible.
Alzheimer's Care
Microstructural MRI techniques, including those developed by Microstructure Imaging, are being explored for their potential in Alzheimer's care. Diffusion tensor imaging (DTI) can reveal how Alzheimer's disease affects white matter microstructure and can help differentiate it from healthy aging or other forms of dementia. Diffusion MRI methods, such as free water imaging and DTI, can also detect gray matter microstructural changes in AD-affected brain regions. MICSI-PET, with its automated amyloid and tau quantification, can aid in the evaluation of Alzheimer's disease.
Physician Tip

Microstructure Imaging's solutions, particularly MICSI-RMT, offer physicians significantly enhanced MRI image quality and reduced noise, especially in diffusion and functional MRI. This translates to clearer visualization of small structures, improved contrast between tissue types, and more anatomically appropriate activation maps in neuroimaging. For prostate imaging, their approach can provide more comprehensive quantitative data (ADC and FA), potentially improving diagnostic accuracy for prostate cancer. The ability to achieve high-quality images with reduced scan times can improve patient comfort, increase throughput, and allow for more advanced imaging techniques in routine clinical practice. Furthermore, their PET enhancement and automated quantification for amyloid and tau can significantly aid in the evaluation and diagnosis of neurodegenerative diseases like Alzheimer's.

MICSI's software, including MICSI-RMT and MICSI-PET, is designed to integrate into existing clinical imaging workflows. MICSI-RMT features DICOM data routing to secure seamless integration into medical workflows. MICSI-PET supports amyloid, tau, and FDG PET and was developed and validated for real-world deployment across PET and MRI systems from major vendors and multiple generations of scanner hardware. The MICSI-RMT algorithm is currently validated for Siemens Healthineers systems.

Products by Microstructure Imaging

No products listed for this company yet. Know of one? Suggest it →

Videos

News, demos, and interviews about Microstructure Imaging.

Loading videos...

Videos load interactively. If none appear, search YouTube for Microstructure Imaging →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Microstructure Imaging utilizes advanced computational techniques to denoise MRI scans and enhance image resolution. This is particularly beneficial in neuroimaging for clearer visualization of brain structures and in prostate imaging for improved lesion detection and characterization, leading to more confident diagnoses.
Yes, our technology provides robust quantitative analysis of DWI, extracting more precise microstructural information from the images. For Alzheimer's care, this can aid in earlier detection of subtle brain changes, monitoring disease progression, and evaluating treatment efficacy, ultimately contributing to more personalized patient management.
Our solutions are designed to optimize MRI protocols, potentially reducing scan times while simultaneously increasing image resolution. This dual benefit allows for greater patient throughput in busy imaging centers and provides physicians with higher-quality images for more accurate and timely diagnoses.
Microstructure Imaging offers specialized software tools that enhance the analysis of neuroimaging data, crucial for Alzheimer's diagnosis and monitoring. These tools are designed for seamless integration into existing PACS and MRI systems, minimizing disruption to current clinical workflows.
Our pricing model is typically subscription-based, offering flexible options to suit different institutional needs. We provide comprehensive technical support, including on-site training and dedicated customer service, to ensure optimal product utilization. Microstructure Imaging is committed to long-term stability, actively pursuing strategic partnerships with leading healthcare providers and research institutions to advance our technology and expand our market reach.

Related Companies

TaxMCP is an AI tool designed for tax professionals, including CPAs, enrolled agents, and tax attorneys, to conduct U.S. federal and state tax research. It functions as a research connector that integrates with AI assistants like Claude and ChatGPT, allowing users to access source-linked tax authority directly within their conversational AI environment. Instead of operating […]

Stanford University, through its online learning platform Stanford Online (online.stanford.edu), provides a wide array of educational opportunities, including those focused on Artificial Intelligence (AI) in healthcare. Stanford Online aims to extend the university’s academic excellence and breakthrough research to a global audience, offering programs taught by Stanford faculty and industry experts. These offerings range from […]

RTW.ai provides scaled CPA services, offering productized accounting, tax preparation, and quarterly insights specifically for owner-led businesses in healthcare, professional services, and the trades. The company aims to eliminate the common frustrations associated with traditional accounting services, such as slow response times and lack of proactive tax planning. They commit to closing books by the […]

Infinitus is a healthcare AI company that develops voice AI agents and copilots to automate administrative workflows for physicians and healthcare providers. The company aims to reduce the complexity and cost of healthcare by handling time-consuming and repetitive phone-based tasks, such as benefit verifications, prior authorizations, patient outreach, and member engagement. By automating these processes, […]

Trainio is an AI roleplay training platform specifically designed for healthcare teams. It allows medical staff, including front desk personnel, call center agents, caregivers, nurses, and pharmacists, to practice challenging patient and family conversations with realistic AI avatars. These scenarios cover a wide range of situations, such as de-escalation of angry patients, communication with individuals […]

Confido Health is an AI-powered healthcare operations platform designed to alleviate administrative burdens for physicians and healthcare providers. The company develops AI agents that automate routine tasks and workflows across various aspects of healthcare operations, including front, mid, and back office functions. This allows medical staff to dedicate more time to direct patient care, improving […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.